Predicting Response to PPI Therapy in GORD Patients
Author Information
Author(s): Robert C Heading, Hubert Mönnikes, Anne Tholen, Holger Schmitt
Primary Institution: Nycomed GmbH
Hypothesis
Can identifiable patient characteristics predict the response to pantoprazole treatment in patients with gastro-oesophageal reflux disease (GORD)?
Conclusion
Identifiable features can help predict symptomatic responses to PPI treatment, aiding in managing patient expectations.
Supporting Evidence
- 58.9% of patients responded to treatment at Week 4 and 71.2% at Week 8.
- Lower BMI and anxiety were associated with poorer treatment responses.
- Concurrent IBS symptoms negatively impacted treatment outcomes.
Takeaway
Doctors can tell if a medicine will work for someone with heartburn by looking at certain signs before they start taking it.
Methodology
A multicentre, multinational, prospective, open study with 1888 GORD patients treated with pantoprazole for 8 weeks, assessing response through questionnaires and clinical evaluations.
Potential Biases
Potential bias from self-reported symptom assessments and the subjective nature of patient satisfaction.
Limitations
The study may not account for all factors influencing treatment response, and the reliance on self-reported measures could introduce bias.
Participant Demographics
Mean age 47 years, 51.8% female, diverse ethnic backgrounds including 70.2% White and 18.6% Asian.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website